Sophia Lu

703 total citations
46 papers, 190 citations indexed

About

Sophia Lu is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Sophia Lu has authored 46 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Genetics. Recurrent topics in Sophia Lu's work include Prostate Cancer Treatment and Research (14 papers), Hormonal and reproductive studies (12 papers) and Estrogen and related hormone effects (10 papers). Sophia Lu is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Hormonal and reproductive studies (12 papers) and Estrogen and related hormone effects (10 papers). Sophia Lu collaborates with scholars based in United States, Canada and Philippines. Sophia Lu's co-authors include Jinky Leilanie Lu, Anu Osinusi, Diana M. Brainard, Kathryn Kersey, Bruce Alan Brown, Neal D. Shore, Ronald Tutrone, Fred Saad, Robert H. Hyland and John G. McHutchison and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Sophia Lu

37 papers receiving 187 citations

Peers

Countries citing papers authored by Sophia Lu

Since Specialization

Citations

This map shows the geographic impact of Sophia Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophia Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophia Lu more than expected).

Fields of papers citing papers by Sophia Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophia Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophia Lu. The network helps show where Sophia Lu may publish in the future.

Co-authorship network of co-authors of Sophia Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Sophia Lu. A scholar is included among the top collaborators of Sophia Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophia Lu. Sophia Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study	JAMA Network Open	Sophia Lu, Alexa Beiser et al.	0
2	Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals	Neurology	Sokratis Charisis, Sophia Lu et al.	1
3	Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer	JAMA Oncology	Daniel E. Spratt, Daniel J. George et al.	4
4	Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes	The Journal of Clinical Endocrinology & Metabolism	Nicole L. Spartano, Honghuang Lin et al.	9
5	Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study	European Urology Oncology	Ronald Tutrone, Fred Saad et al.	6
6	Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer	Clinical Genitourinary Cancer	Daniel J. George, Fred Saad et al.	6
7	Association between acoustic features and brain volumes: the Framingham Heart Study	SHILAP Revista de lepidopterología	Huitong Ding, Cody Karjadi et al.	3
8	Establishing cognitive baseline in three generations: Framingham Heart Study	Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	Ting Fang Alvin Ang, Sophia Lu et al.	2
9	A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer	Targeted Oncology	Curtis Dunshee, Paul Sieber et al.	7
10	Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer	Advances in Therapy	Neal D. Shore, Bryan A. Mehlhaff et al.	4
11	Association Between Acoustic Features and Neuropsychological Test Performance in the Framingham Heart Study: Observational Study	Journal of Medical Internet Research	Huitong Ding, Cody Karjadi et al.	7
12	Proteins as Mediators of the Association Between Diet Quality and Incident Cardiovascular Disease and All‐Cause Mortality: The Framingham Heart Study	Journal of the American Heart Association	You Jin Kim, Sophia Lu et al.	18
13	Assessing the Association Between the Night Shift Schedule and Mental Health Symptoms among Filipino Women Factory Workers: A Cross-Sectional Study	Journal of international women's studies	Sophia Lu, Jinky Leilanie Lu	1
14	622P Geographical assessment of efficacy and safety of relugolix: A subgroup analysis from the randomized, phase III HERO study vs leuprolide (LEU) in men with advanced prostate cancer (APC)	Annals of Oncology	Alberto Bossi, Neal D. Shore et al.	0
15	The Electoral Quota—A Form of Gender Quota to Increase Women’s Participation in Parliament: A Quantitative Study from a Survey in the Middle East	Journal of international women's studies	Sophia Lu, Jinky Leilanie Lu	4
16	Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India	Hepatology International	Ajit Sood, Ajay Duseja et al.	14
17	Tu1501 – Ledipasvir/Sofosbuvir for 8, 12, Or 24 Weeks is Safe and Effective in Patients Undergoing Dialysis	Gastroenterology	Wan‐Long Chuang, Tsung‐Hui Hu et al.	1
18	Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt	Gut	Gamal Shiha, Gamal Esmat et al.	34
19	Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection	Clinical Drug Investigation	Isakov Va, Natalia Gankina et al.	8
20	Formal Institutions and Women's Electoral Representation in Four European Countries: Belgium, Germany, Italy, the Netherlands	Journal of international women's studies	Sophia Lu	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact